| LIRRX | VIHAX | LIRRX / VIHAX | |
| Total Expense Ratio | 1.24 | 0.17 | 729% |
| Annual Report Gross Expense Ratio | 1.24 | 0.17 | 729% |
| Fund Existence | 17 years | 10 years | - |
| Gain YTD | 25.439 | 25.559 | 100% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 455M | 13.8B | 3% |
| Annual Yield % from dividends | 2.59 | 3.92 | 66% |
| Returns for 1 year | 24.12 | 22.21 | 109% |
| Returns for 3 years | 56.12 | 47.08 | 119% |
| Returns for 5 years | 52.00 | 53.96 | 96% |
| Returns for 10 years | 68.75 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FMED | 27.76 | 0.52 | +1.91% |
| Fidelity Disruptive Medicine ETF | |||
| DHS | 100.80 | 1.43 | +1.44% |
| WisdomTree US High Dividend ETF | |||
| AMZY | 13.17 | 0.17 | +1.31% |
| YieldMax AMZN Option Income Strategy ETF | |||
| PSTR | 28.27 | 0.25 | +0.89% |
| PeakShares Sector Rotation ETF | |||
| GBXC | 26.50 | 0.15 | +0.57% |
| Goldman Sachs U.S. Lg Cp Buffr 3 ETF | |||